Dr. Simuni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
259 E Erie St
Chicago, IL 60611Phone+1 312-503-1944
Education & Training
Temple University HospitalResidency, Neurology, 1991 - 1995
Albert Einstein Healthcare NetworkInternship, Internal Medicine, 1990 - 1991
St Petersburg State Pediatric Medicine AcademyClass of 1985
Certifications & Licensure
IL State Medical License 1996 - 2026
PA State Medical License 1993 - 2002
NJ State Medical License 1995 - 2001- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial.Niraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, Brian T Harel, Hongxia Jia
JAMA Neurology. 2025-01-06 - A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's ...Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, Tanya Simuni, Kenneth Marek
Parkinsonism & Related Disorders. 2024-12-29 - Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.Ethan G Brown, Lana M Chahine, Andrew Siderowf, Caroline Gochanour, Ryan Kurth
Annals of Neurology. 2024-12-24
Press Mentions
Staging System Predicts Early-Stage Parkinson’s Time to ProgressionDecember 5th, 2024- Improving Diagnosis and Tracking of Neurodegenerative DiseasesNovember 22nd, 2024
- Investigational Med for Tourette Syndrome PromisingOctober 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
